Literature DB >> 21564294

Biological variability of C-reactive protein and specific canine pancreatic lipase immunoreactivity in apparently healthy dogs.

P C Carney1, C G Ruaux, J S Suchodolski, J M Steiner.   

Abstract

BACKGROUND: C-reactive protein (CRP) and specific canine pancreatic lipase immunoreactivity (Spec cPL) are biomarkers of generalized or nonspecific inflammation and pancreatic inflammation in dogs, respectively. The extent of inter- and intraindividual variation over time of these analytes is not well defined in dogs. The minimal critical difference for sequential determinations of these markers (ie, the smallest change necessary to represent physiological change rather than biological variation), has not been defined.
OBJECTIVES: To determine the inter- and intraindividual variability (CV(G) and CV(I) ) and minimal critical difference for sequential determinations of serum CRP and Spec cPL concentrations in apparently healthy dogs. ANIMALS: Eleven apparently healthy dogs owned by staff or students at a veterinary teaching hospital.
METHODS: Blood was collected repeatedly at varying intervals over 12 weeks. CRP and Spec cPL concentrations were determined with commercially available assays. Indices of inter-, intraindividual, and assay variability and 1-sided minimal critical differences for sequential concentrations were calculated.
RESULTS: For CRP, CV(G) was 90.8%, CV(I) was 115.5%, and the analytical variability (CV(A) ) was 6.3%; the index of individuality was 0.74, and 1-sided critical difference was 269.9%. For Spec cPL, CV(G) = 49.48%, CV(I) = 193.8%, CV(A) = 8.4%, index of individuality = 0.24, and 1-sided critical difference was 452.6%. CONCLUSIONS AND CLINICAL IMPORTANCE: A population-based reference range is appropriate for Spec cPL, but questionable for CRP in dogs. Large changes in serial measurements of Spec cPL are necessary to infer clinical importance, more modest changes in CRP are likely to be meaningful.
Copyright © 2011 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564294     DOI: 10.1111/j.1939-1676.2011.0729.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  15 in total

1.  Hematologic and Biochemical Biologic Variation in Laboratory Cats.

Authors:  Catherine Trumel; Céline Monzali; Anne Geffré; Didier V Concordet; Louise Hourqueig; Jean-Pierre D Braun; Nathalie H Bourgès-Abella
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

2.  Effects of immunosuppressive prednisolone therapy on pancreatic tissue and concentration of canine pancreatic lipase immunoreactivity in healthy dogs.

Authors:  Hiroshi Ohta; Kazuki Kojima; Nozomu Yokoyama; Noboru Sasaki; Yumiko Kagawa; Kiwamu Hanazono; Tomohito Ishizuka; Keitaro Morishita; Kensuke Nakamura; Satoshi Takagi; Mitsuyoshi Takiguchi
Journal:  Can J Vet Res       Date:  2018-10       Impact factor: 1.310

3.  Validation of a commercially available automated canine-specific immunoturbidimetric method for measuring canine C-reactive protein.

Authors:  Anna Hillström; Ragnvi Hagman; Harold Tvedten; Mads Kjelgaard-Hansen
Journal:  Vet Clin Pathol       Date:  2014-05-05       Impact factor: 1.180

4.  Variability of Symmetric Dimethylarginine in Apparently Healthy Dogs.

Authors:  M A Kopke; R K Burchell; C G Ruaux; S E Burton; N Lopez-Villalobos; A Gal
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

5.  Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.

Authors:  Romy M Heilmann; Nora Berghoff; Joanne Mansell; Niels Grützner; Nolie K Parnell; Corinne Gurtner; Jan S Suchodolski; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-02-20       Impact factor: 3.333

6.  Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy.

Authors:  J D Foster; S Sample; R Kohler; K Watson; P Muir; L A Trepanier
Journal:  J Vet Intern Med       Date:  2014-04-03       Impact factor: 3.333

7.  Agreement of serum Spec cPL with the 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase assay and with pancreatic ultrasonography in dogs with suspected pancreatitis.

Authors:  P H Kook; N Kohler; S Hartnack; B Riond; C E Reusch
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

8.  Histopathological findings and canine pancreatic lipase immunoreactivity in normal dogs and dogs with inflammatory and neoplastic diseases of the pancreas.

Authors:  Heike Aupperle-Lellbach; Katrin Törner; Marlies Staudacher; Christina Stadler; Ursula Tress; Julia M Grassinger; Elisabeth Müller; Corinna N Weber
Journal:  J Vet Intern Med       Date:  2020-05-07       Impact factor: 3.333

Review 9.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

10.  Serum canine pancreatic-specific lipase concentrations in dogs with naturally occurring Babesia rossi infection.

Authors:  Liza S Köster; Jörg M Steiner; Jan S Suchodolski; Johan P Schoeman
Journal:  J S Afr Vet Assoc       Date:  2015-08-13       Impact factor: 1.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.